More data from PAISLEY, deucravacitinib in SLE Small but significant benefit w/respect to joints, a little disappointin
Tweet Content
More data from PAISLEY, deucravacitinib in SLE
Small but significant benefit w/respect to joints, a little disappointing tbh
Would like to see this for all manifestations ie pericarditis, pleuritis, etc
Anyone have an infographic or useful chart?
#ACR20 @RheumNow Abstr#1552 https://t.co/tXUoUtssxo
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off